NewslettersExtracellular Matrix NewsOsteopontin Is a Therapeutic Target That Drives Breast Cancer RecurrenceBy Emily Salmini - October 24, 2024079Investigators identified tumor cell-derived osteopontin as an autocrine and paracrine driver of tumor recurrence.[Nature Communications]Full Article